Alzheimer's Association Research Grants

Alzheimer's Association Research Grants is sponsored by Alzheimer's Association. The Alzheimer's Association is the world's largest non-profit funder of Alzheimer's and dementia research, funding a wide range of projects from basic discovery science to social and behavioral aspects.

Types of Grants | Alzheimer's Association View and Apply for a Grant View and Apply for a Grant The Alzheimer's Association works to identify and fund a wide range of the most promising grant projects, from basic discovery science to studies addressing social and behavioral aspects of Alzheimer's and related dementias.

Alzheimer’s Association Clinician Scientist Fellowship for All (AACSFA) Program Alzheimer’s Association Research Fellowship for All (AARFA) Program Alzheimer’s Association Research Grant For All (AARGA) Program Alzheimer’s Association AI-BOND Leaders (ALZ AI-BOND) Pilot Awards in Brain Health Program Alzheimer’s Disease Strategic Fund: Vascular Contributions to Cognitive Impairment and Dementia 2026 – Understanding Mechanisms of Dysfunction (VCID-UMD) Program Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN): Powering the Next Generation of Research Tau Pipeline Enabling Program V (T-PEP) Capacity Building in International Dementia Research (CBIDR) Program Health Services Research in Alzheimer’s Disease and Related Disorders (HSR-ADRD) Funding Program Alzheimer's Association Funding Program for Global Real-World Data Programs (ALZ-RWD) Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP) Active Alzheimer's Association Grants The following funding programs are accepting letters of intent (LOI) or applications at this time.

View the granfts' eligibility and deadlines. You can also select a grant for more information. The majority of our grants are open to U.S. and international researchers.

Alzheimer’s Association Clinician Scientist Fellowship for All (AACSFA) Program The Alzheimer’s Association recognizes the need to support the training of clinician scientists in Alzheimer’s and all other dementias.

For the purpose of this program, a clinician scientist is defined as an individual already trained, licensed and practicing in a clinical field that includes patient contact (e.g., neurology, psychiatry, geriatrics, psychology) or patient-related diagnostic studies (e.g., neuropathology and radiology). Aug. 14, 2026 – 5 p.

m. ET Oct. 14, 2026 – 5 p.

m. ET Alzheimer’s Association Research Fellowship for All (AARFA) Program The Alzheimer’s Association recognizes the importance of supporting the early career development of promising researchers working to advance the understanding, diagnosis, and treatment of Alzheimer’s and all other dementias.

Alzheimer’s Association Research Fellowship for All (AARFA) Program is designed to nurture the next generation of scientists by providing funding to postdoctoral researchers who have completed their doctoral training and are actively working in Alzheimer’s or dementia-related research under the mentorship of established investigators.

This program aims to facilitate the transition of early career investigators toward becoming independent researchers, equipped to lead their own innovative studies in the field of Alzheimer’s and related dementias. Aug. 14, 2026 – 5 p.

m. ET Oct. 14, 2026 – 5 p.

m. ET Alzheimer’s Association Research Grant for All (AARGA) Program The Alzheimer’s Association Research Grant for All (AARGA) program aims to fund early-career investigators who have been in the position of Assistant Professor or the equivalent for no more than seven (7) years.

The purpose of this program is to provide newly independent investigators with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. The intent is to support early-career development of newly independent researchers/clinicians that will lay the groundwork for future research grant applications to federal or other funding entities. Aug.

14, 2026 – 5 p. m. ET Oct.

14, 2026 – 5 p. m. ET Alzheimer’s Association AI-BOND Leaders (ALZ AI-BOND) Pilot Awards in Brain Health Program The ALZ AI-BOND Pilot Awards support AI-BOND alumni and scholars in advancing data analysis capacity in brain health, Alzheimer’s and other neurodegenerative diseases in Africa.

This invitation-only pilot leverages the overlapping missions of the Alzheimer’s Association and the African Initiative for Bioinformatics Online Training in Neurodegenerative Diseases (AI- BOND) program to advance AD/ADRD research led by African scientists. Projects must use a bioinformatics-focused secondary data analysis approach, with preference for proposals that elevate African data sets or Africa-specific questions.

This grant is only open to applicants who are currently enrolled or have successfully completed the AI BOND training program . July 31, 2026 – 5 p. m.

ET Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN): Powering the Next Generation of Research U.S. federal government-sponsored research funding has experienced a series of changes that challenges ongoing research initiatives and the future of the U.S. biomedical research enterprise.

This program specifically aims to ensure continuity of career support for early career researchers and researchers who are within seven years of their designation as an Early Stage Investigator (ESI) based on the NIH definition. This program will provide funding for salary and other direct costs for research projects. July 30, 2026; Oct.

30, 2026; Jan.

29, 2027; April 30, 2027 Invited applicants will receive a specific submission deadline (within four weeks of the invitation) and instructions for application submission Within three months of LOI submission Alzheimer’s Disease Strategic Fund: Vascular Contributions to Cognitive Impairment and Dementia 2026 – Understanding Mechanisms of Dysfunction (VCID-UMD) Program The Alzheimer’s Association aims to support innovative, high-risk, collaborative team science opportunities that investigate and focus on outstanding questions related to the biological underpinnings of Alzheimer’s disease (AD), including the vascular contributions to cognitive impairment and dementia (VCID).

This funding call will be supported through an innovative funding model, the Alzheimer’s Disease Strategic Fund (ADSF), established in 2019 to support studies that advance our mechanistic understanding of disease biology. June 15, 2026 – 5 p. m.

ET Sept. 14, 2026 – 5 p. m.

ET Tau Pipeline Enabling Program V (T-PEP) T-PEP supports translational projects aimed at advancing potential therapies for tauopathies, including Alzheimer's disease, progressive supranuclear palsy (PSP), and frontotemporal dementia (FTD). The program focuses on development candidate selection, lead optimization, in vivo proof-of-concept, and IND-enabling studies for tau or tau-related mechanisms.

Projects centered on compound or target discovery are not responsive. April 13, 2026 – 5 p. m.

ET Letter of Intent deadline: Full application deadline: Aug. 14, 2026 – 5 p. m.

ET Capacity Building in International Dementia Research (CBIDR) Program The CBIDR grant explicitly targets capacity building for scientific investigation within institutions located in Low- and Middle-Income countries (LMIC) where prior research funding has been received, but barriers to sustainability exist. Letter of Intent deadline: June 3, 2026 – 5 p. m.

ET Application deadline: Sept. 2, 2026 – 5 p. m.

ET Award notifications: By Dec. 30, 2026 Alzheimer’s Association Health Services Research in Alzheimer’s Disease and Related Disorders (HSR-ADRD) Program The HSR-ADRD program seeks to support research that strengthens dementia detection, diagnosis, and post-diagnostic care pathways along the care continuum.

Projects may address a range of health services research questions, including, but not limited to, studies examining barriers and solutions to timely access, quality, and care coordination. By supporting rigorous and innovative research, this program aims to generate actionable evidence to improve person-centered, coordinated, and equitable brain health and dementia care. Letter of Intent deadline: May 6, 2026 – 5 p.

m. ET Application deadline: July 22, 20265 – 5 p. m.

ET Award notifications: By Nov. 30, 2026 Alzheimer's Association Funding Program for Global Real-Word Data Programs (ALZ-RWD) Support the infrastructure, data and/or impact of a RWD platform that has, or plans to have, international, national or significant regional reach. Enhance alignment and collaboration between global platforms, including with ALZ-NET.

Have the potential to advance health equity. Pre-submission inquiries are accepted at any time. Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP) Applicants must be a member of the World Wide FINGERS Network.

Studies must be equivalent in planning to a Level 2 or Level 1, as described in Kivipelto et al. (2020) Alzheimer’s & Dementia . Pre-submission inquiries are accepted at any time.

Keep Up With Alzheimer's News and Events Yes, I would like to receive email from the Alzheimer's Association. * hidden field used for source value to collect web page domain hidden field used for subsource value to collect web page url